Ergebnisseite 11 für Wirtschaftszweig: Gesundheitswesen Branche: Biotechnologie Aktienmarkt – Aktienkurse & Preise
Liste aller Aktien und Wertpapiere mit Preisen, Marktkapitalisierungen, KGV und EPS
Alle Länder
- {{country.name}}
- Alle Länder
- Vereinigte Staaten (1012)
- Australien (58)
- Österreich (16)
- Belgien (7)
- Brasilien (16)
- Kanada (83)
- China (94)
- Dänemark (6)
- Finnland (4)
- Frankreich (41)
- Deutschland (738)
- Hongkong (46)
- Indien (19)
- Irland (1)
- Israel (19)
- Italien (4)
- Japan (37)
- Mexiko (28)
- Niederlande (3)
- Neuseeland (1)
- Norwegen (14)
- Polen (9)
- Russland (2)
- Südkorea (12)
- Spanien (4)
- Schweden (70)
- Schweiz (11)
- Taiwan (67)
- Thailand (2)
- Türkei (1)
- Vereinigtes Königreich (69)
Alle Börsen
- {{item.name}}
- Alle Börsen
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Gesundheitswesen (2611)
- {{item.name}}
- Alle Bereiche
- Gesundheitswesen (2611)
Biotechnologie (2611)
- {{item.name}}
- Alle Branchen
- Biotechnologie (2611)
- Arzneimittelhersteller-Allgemeines (279)
- Arzneimittelherstellern-Spezielle und Generische (1705)
- Gesundheitsprogrammen (57)
- Medizinische Versorgungseinrichtungen (553)
- Pharmazeutischen Einzelhändler (155)
- Gesundheitsinformationsdienste (419)
- Medizinische Geräte (913)
- Medizinische Geräte und Materialien (501)
- Medizinische Diagnostik und Forschung (427)
- Medizinische Vertrieb (138)
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Neutra NTRR | $0.0002 — |
0
|
$583.58K — | $7.2M — | $0.0002 — | $0.0002 — | $583.58K — | 0 | $0 — | |
| Bonus BioGroup Ltd. BONS.TA | $14.8 0.04 USD |
+1.37
|
$172.85M 504.03K USD | $2.67M 7.79K USD | $14.8 0.04 USD | $16.2 0.05 USD | $172.85M 504.03K USD | 0 | -$0.04 -0.0001 USD | |
| NanoSphere Health Sciences Inc. NSHS.CN | $0.07 0.05 USD |
0
|
$667.89K 495.61K USD | $0 0 USD | $0 0 USD | $0 0 USD | $667.89K 495.61K USD | 0 | -$0.01 -0.007 USD | |
| Hepion Pharmaceuticals, Inc. HEPA | $0.44 — |
-4.37
|
$475.2K — | $1.35M — | $0.39 — | $0.46 — | $475.2K — | 0 | -$220 — | |
| Kiromic BioPharma KRBP | $0.1199 — |
0
|
$318.42K — | $42.93K — | $0.1799 — | $0.3099 — | $318.42K — | 0 | -$3.17 — | |
| Amarantus BioScience AMBS | $0.0005 — |
0
|
$315.2K — | $100.1K — | $0.0001 — | $0.0001 — | $315.2K — | 0 | -$0.04 — | |
| CNBX Pharmaceuticals CNBX | $0.01 — |
0
|
$311.11K — | $28.11K — | $0.007599 — | $0.007599 — | $311.11K — | 0 | -$0.02 — | |
| TransCode Therapeutics RNAZ | $0.45 — |
-2.88
|
$309.83K — | $1.53M — | $0.4099 — | $0.4799 — | $309.83K — | 0.000079 | $5.57K — | |
| GlobeStar Therapeutics GSTC | $0.0002 — |
0
|
$248.22K — | $1M — | $0.0002 — | $0.0002 — | $248.22K — | 0 | $0 — | |
| Mera Pharmaceuticals MRPI | $0.0001 — |
0
|
$222.92K — | $4.42M — | $0.0001 — | $0.0001 — | $222.92K — | 0 | $0 — | |
| Scandion Oncology A/S SCOL.ST | $0.0097 0.00094 USD |
0
|
$2.28M 222.28K USD | $303.63K 29.64K USD | $0.0097 0.00094 USD | $0.0097 0.00094 USD | $2.28M 222.28K USD | 0 | -$0.24 -0.02 USD | |
| Endonovo Therapeutics ENDV | $0.0002 — |
0
|
$219.58K — | $14.49M — | $0.0002 — | $0.0002 — | $219.58K — | 0 | $0 — | |
| Wesana Health WSNAF | $0.01 — |
0
|
$209.2K — | $9.92K — | $0.02999 — | $0.04 — | $209.2K — | 0 | -$0.02 — | |
| GB Sciences GBLX | $0.0002999 — |
0
|
$122.12K — | $30.03K — | $0.0002999 — | $0.0002999 — | $122.12K — | 0 | $0 — | |
| BioLineRx Ltd. BLRX.TA | $1.7 0.0049 USD |
0
|
$37.95M 110.67K USD | $520.98K 1.52K USD | $1.7 0.0049 USD | $1.7 0.0049 USD | $37.95M 110.67K USD | 0 | -$0.04 -0.0001 USD | |
| Innovation Pharmaceuticals IPIX | $0.0002 — |
0
|
$103.67K — | $2.4K — | $0.0002 — | $0.0002 — | $103.67K — | 0 | -$0.01 — | |
| Can-Fite BioPharma Ltd. CANF.TA | $1.9 0.0055 USD |
+5.88
|
$34.75M 101.33K USD | $150K 437.39 USD | $1.9 0.0055 USD | $1.9 0.0055 USD | $34.75M 101.33K USD | 0 | -$0.03 -0.00008 USD | |
| Neovacs S.A. ALNEV.PA | $0.02999 0.04 USD |
-8.29
|
$85.22K 93.16K USD | $67.76K 74.08K USD | $0.02999 0.03 USD | $0.02999 0.04 USD | $85.22K 93.16K USD | 0 | -$37,997 -41536.07 USD | |
| Propanc Biopharma PPCB | $5 — |
+42.86
|
$76.86K — | $110 — | $3.5 — | $5 — | $76.86K — | 0 | -$116.1 — | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $35.5K — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Navidea Biopharmaceuticals NAVB | $0.0005999 — |
0
|
$60.05K — | $945 — | $0.0002999 — | $0.0002999 — | $60.05K — | 0 | -$0.2 — | |
| Better Therapeutics BTTX | $0.0004 — |
0
|
$21.81K — | $686 — | $0.0002999 — | $0.0002999 — | $21.81K — | 0 | -$1.1 — | |
| Q BioMed QBIO | $0.0001 — |
-50
|
$14.51K — | $400 — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Statera Biopharma STAB | $0.0001 — |
0
|
$7.14K — | $3.57K — | $0.0001 — | $0.0001 — | $7.14K — | 0 | -$2.36 — | |
| Calithera Biosciences CALA | $0.001 — |
0
|
$4.87K — | $200 — | $0.0001 — | $0.0001 — | $4.87K — | 0 | -$13.23 — | |
| Molecular Templates MTEM | $0.0001 — |
0
|
$658 — | $4.52K — | $0.0002 — | $0.0002 — | $658 — | 0 | -$3.05 — | |
| NLS Pharmaceutics NLSPW | $0.006 — |
-40
|
$0 — | $324.46K — | $0.0008999 — | $0.008699 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $46.6 9.45 USD |
+1.35
|
$1.66T 335.92B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.66T 335.92B USD | 19.17 | $2.43 0.49 USD | |
| Novo Nordisk A/S NOVA.F | $59.4 64.93 USD |
+3.13
|
$266.87B 291.73B USD | $73 79.8 USD | $59.4 64.93 USD | $59.4 64.93 USD | $266.87B 291.73B USD | 19.60 | $3.03 3.31 USD | |
| Novo Nordisk A/S NVON.MX | $1,320.01 78.16 USD |
+2.36
|
$3.04T 180.25B USD | $542 32.09 USD | $1,295 76.68 USD | $1,340 79.34 USD | $3.04T 180.25B USD | 21.25 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $9,680.59 573.21 USD |
0
|
$2.52T 149.19B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.52T 149.19B USD | 0 | -$42.59 -2.5 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $703.34 142.56 USD |
+1.18
|
$723.26B 146.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $723.26B 146.59B USD | 0 | -$3.02 -0.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $431.95 472.18 USD |
+2.54
|
$113.91B 124.52B USD | $70 76.52 USD | $431.95 472.18 USD | $431.95 472.18 USD | $113.91B 124.52B USD | 0 | -$1.9 -2.07 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $435.1 462.94 USD |
+2.74
|
$111.08B 121.43B USD | $226 247.05 USD | $400.5 437.8 USD | $429.4 469.39 USD | $111.08B 121.43B USD | 0 | -$1.91 -2.08 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $426.75 466.5 USD |
-2.92
|
$111.08B 121.43B USD | $457 499.56 USD | $390.55 426.92 USD | $438.05 478.85 USD | $111.08B 121.43B USD | 0 | -$1.88 -2.05 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $13,011.61 770.45 USD |
0
|
$1.4T 82.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.4T 82.83B USD | 16.42 | $792.41 46.92 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $57.25 11.6 USD |
0
|
$369.29B 74.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $369.29B 74.85B USD | 15.34 | $3.73 0.76 USD | |
| CSL Limited CSJ.F | $134.38 146.9 USD |
+2.19
|
$66.06B 72.22B USD | $5 5.47 USD | $134.38 146.9 USD | $134.38 146.9 USD | $66.06B 72.22B USD | 27.20 | $4.94 5.4 USD | |
| CSL CMXHF | $143.04 — |
-1.35
|
$70.1B — | $100 — | $145 — | $145 — | $70.1B — | 26.24 | $5.45 — | |
| CSL Limited CSJA.F | $66 72.15 USD |
0
|
$63.92B 69.87B USD | $6 6.56 USD | $66 72.15 USD | $66 72.15 USD | $63.92B 69.87B USD | 26.61 | $2.48 2.71 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $515.6 563.62 USD |
-4.48
|
$57.02B 62.33B USD | $181 197.86 USD | $495.2 541.32 USD | $522 570.62 USD | $57.02B 62.33B USD | 14.72 | $35.01 38.27 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,004,000 757.86 USD |
-0.4
|
$71.46T 53.94B USD | $145.4K 109.75 USD | $1,001,000 755.59 USD | $1,033,000 779.75 USD | $71.46T 53.94B USD | 0 | $0 0 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE ARGNF | $697.42 — |
0
|
$42.54B — | $5 — | $695.15 — | $695.15 — | $42.54B — | 54.65 | $12.76 — | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $133.25 27.01 USD |
0
|
$203.18B 41.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $203.18B 41.18B USD | 44.71 | $2.98 0.6 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $77.54 15.72 USD |
0
|
$200.71B 40.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $200.71B 40.68B USD | 0 | -$0.64 -0.1 USD | |
| argenx SE ARGX.VI | $494.7 540.77 USD |
-5.81
|
$31.74B 34.7B USD | $0 0 USD | $488.7 534.22 USD | $495.3 541.43 USD | $31.74B 34.7B USD | 42.39 | $11.67 12.76 USD | |
| argenx SE 1AE.F | $501.6 548.32 USD |
+2.7
|
$31.47B 34.4B USD | $7 7.65 USD | $501.6 548.32 USD | $501.6 548.32 USD | $31.47B 34.4B USD | 43.31 | $11.58 12.66 USD | |
| argenx SE 1AEA.F | $498 544.38 USD |
+3.32
|
$31.06B 33.95B USD | $1 1.09 USD | $498 544.38 USD | $498 544.38 USD | $31.06B 33.95B USD | 43.11 | $11.55 12.63 USD | |
| UCB SA UCBJF | $170 — |
0
|
$32.31B — | $17 — | $175 — | $175 — | $32.31B — | 28.33 | $6 — | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $213.9 233.82 USD |
+4.85
|
$28.77B 31.45B USD | $4 4.37 USD | $213.9 233.82 USD | $213.9 233.82 USD | $28.77B 31.45B USD | 0 | -$1.98 -2.1 USD | |
| UCB SA UNC.F | $147.45 161.18 USD |
+0.07
|
$28.65B 31.32B USD | $55 60.12 USD | $147.45 161.18 USD | $147.45 161.18 USD | $28.65B 31.32B USD | 26.90 | $5.48 5.99 USD | |
| UCB SA UCB.VI | $141.3 154.46 USD |
-7.74
|
$28.63B 31.3B USD | $0 0 USD | $141.3 154.46 USD | $143.7 157.08 USD | $28.63B 31.3B USD | 25.78 | $5.48 5.99 USD | |
| UCB SA UNC0.F | $72.5 79.25 USD |
+5.07
|
$28.05B 30.67B USD | $50 54.66 USD | $72.5 79.25 USD | $72.5 79.25 USD | $28.05B 30.67B USD | 26.45 | $2.74 3 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. 49BA.F | $208 227.37 USD |
0
|
$26.68B 29.17B USD | $5 5.47 USD | $193 210.98 USD | $208 227.37 USD | $26.68B 29.17B USD | 0 | -$5.54 -6.05 USD | |
| Celltrion, Inc. 068270.KS | $163,100 123.11 USD |
-0.79
|
$35.51T 26.8B USD | $594.36K 448.65 USD | $162,900 122.96 USD | $166,900 125.98 USD | $35.51T 26.8B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| BioNTech SE B1NT34.SA | $31.72 6.43 USD |
-2.4
|
$122B 24.73B USD | $0 0 USD | $0 0 USD | $0 0 USD | $122B 24.73B USD | 0 | -$1.11 -0.2 USD | |
| BeiGene, Ltd. 49B.F | $14.46 15.8 USD |
+1.55
|
$21.97B 24.01B USD | $200 218.63 USD | $14.46 15.8 USD | $14.46 15.8 USD | $21.97B 24.01B USD | 0 | -$0.43 -0.4 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $77.55 84.77 USD |
-4.02
|
$19.13B 20.92B USD | $1.11K 1.21K USD | $72.4 79.14 USD | $78.35 85.65 USD | $19.13B 20.92B USD | 0 | -$2.77 -3.02 USD | |
| BioNTech SE 22UA.F | $79.4 86.79 USD |
+0.51
|
$19.09B 20.86B USD | $43 47 USD | $79.4 86.79 USD | $79.4 86.79 USD | $19.09B 20.86B USD | 0 | -$2.77 -3.02 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $28.5 31.15 USD |
+10.77
|
$18.04B 19.72B USD | $320 349.8 USD | $28.5 31.15 USD | $28.5 31.15 USD | $18.04B 19.72B USD | 16.37 | $1.74 1.9 USD | |
| Royalty Pharma plc RPD.MU | $28.49 31.14 USD |
+3.19
|
$16.81B 18.37B USD | $0 0 USD | $28.49 31.14 USD | $28.49 31.14 USD | $16.81B 18.37B USD | 16.37 | $1.74 1.9 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$282.35B 16.72B USD | $0 0 USD | $0 0 USD | $0 0 USD | $282.35B 16.72B USD | 32.47 | $45.58 2.7 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Incyte Corporation I1NC34.SA | $209 42.36 USD |
0
|
$80.89B 16.4B USD | $0 0 USD | $209 42.36 USD | $209 42.36 USD | $80.89B 16.4B USD | 475.00 | $0.44 0.09 USD | |
| Incyte Corporation INCY.MX | $1,430.49 84.7 USD |
0
|
$276.83B 16.39B USD | $0 0 USD | $1,430.49 84.7 USD | $1,430.49 84.7 USD | $276.83B 16.39B USD | 454.12 | $3.15 0.19 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $208.72 42.3 USD |
0
|
$79.64B 16.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $79.64B 16.14B USD | 32.35 | $6.45 1.31 USD | |
| WuXi Biologics (Cayman) WXIBF | $3.7 — |
0
|
$15.16B — | $2.2K — | $3.48 — | $3.55 — | $15.16B — | 33.63 | $0.11 — | |
| United Therapeutics Corporation UTH.F | $267 291.87 USD |
+9.97
|
$13.12B 14.34B USD | $23 25.14 USD | $267 291.87 USD | $267.9 292.85 USD | $13.12B 14.34B USD | 11.90 | $22.43 24.52 USD | |
| Insmed Incorporated IM8N.SG | $62.5 68.32 USD |
+13.64
|
$12.81B 14B USD | $0 0 USD | $62.5 68.32 USD | $62.5 68.32 USD | $12.81B 14B USD | 0 | -$5.07 -5.5 USD | |
| Insmed Incorporated IM8N.F | $62 67.77 USD |
+4.2
|
$11.75B 12.84B USD | $435 475.51 USD | $62 67.77 USD | $62 67.77 USD | $11.75B 12.84B USD | 0 | -$5.07 -5.5 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Incyte Corporation ICY.F | $55.34 60.49 USD |
+6.06
|
$11.28B 12.33B USD | $6 6.56 USD | $55.34 60.49 USD | $55.34 60.49 USD | $11.28B 12.33B USD | 395.28 | $0.14 0.15 USD | |
| Moderna, Inc. MRNA.MX | $522 30.91 USD |
+0.19
|
$204.72B 12.12B USD | $234 13.86 USD | $507 30.02 USD | $540 31.97 USD | $204.72B 12.12B USD | 0 | -$191.6 -11.3 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $54.38 59.44 USD |
+6.71
|
$10.97B 11.99B USD | $36 39.35 USD | $54.38 59.44 USD | $54.38 59.44 USD | $10.97B 11.99B USD | 27.05 | $2.01 2.2 USD | |
| Genmab A/S GNMSF | $181.34 — |
0
|
$11.52B — | $31 — | $190.5 — | $191.15 — | $11.52B — | 10.10 | $17.95 — | |
| Genmab A/S GMAB.VI | $163.85 179.11 USD |
-3.08
|
$10.49B 11.46B USD | $0 0 USD | $160.5 175.45 USD | $163.85 179.11 USD | $10.49B 11.46B USD | 9.99 | $16.4 17.93 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $52.66 57.56 USD |
-8.77
|
$10.28B 11.24B USD | $192 209.88 USD | $51 55.75 USD | $53.74 58.75 USD | $10.28B 11.24B USD | 26.06 | $2.02 2.21 USD | |
| Exelixis, Inc. EX9.F | $31.73 34.69 USD |
+6.69
|
$9.48B 10.36B USD | $500 546.57 USD | $31.73 34.69 USD | $31.73 34.69 USD | $9.48B 10.36B USD | 19.83 | $1.6 1.75 USD | |
| Moderna, Inc. 0QF.F | $23.81 26.03 USD |
+2.41
|
$9.24B 10.1B USD | $150 163.97 USD | $23.81 26.03 USD | $24.2 26.45 USD | $9.24B 10.1B USD | 0 | -$8.45 -9.2 USD | |
| Ascendis Pharma A/S A1SN34.SA | $54.36 11.02 USD |
-2.05
|
$49.25B 9.98B USD | $0 0 USD | $0 0 USD | $0 0 USD | $49.25B 9.98B USD | 0 | -$41.92 -8.4 USD | |
| Moderna, Inc. 0QF.MU | $23.45 25.63 USD |
+7.79
|
$9.06B 9.91B USD | $0 0 USD | $23.45 25.63 USD | $23.45 25.63 USD | $9.06B 9.91B USD | 0 | -$8.45 -9.2 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.99 2.02 USD |
-1.28
|
$48.34B 9.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $48.34B 9.8B USD | 52.57 | $0.19 0.04 USD | |
| Moderna, Inc. MRNA.VI | $22.72 24.83 USD |
+0.46
|
$8.79B 9.61B USD | $2.09K 2.28K USD | $20.81 22.74 USD | $22.72 24.83 USD | $8.79B 9.61B USD | 0 | -$8.55 -9.3 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $4.02 4.39 USD |
-6.94
|
$8.23B 9B USD | $1.76K 1.92K USD | $4.02 4.39 USD | $4.02 4.39 USD | $8.23B 9B USD | 20.10 | $0.2 0.22 USD | |
| Sino Biopharmaceutical SBHMY | $9.75 — |
0
|
$8.86B — | $100 — | $10.3 — | $10.3 — | $8.86B — | 33.62 | $0.29 — | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Ascendis Pharma A/S A71.F | $128 139.92 USD |
+3.33
|
$7.7B 8.41B USD | $50 54.66 USD | $128 139.92 USD | $128 139.92 USD | $7.7B 8.41B USD | 0 | -$6.53 -7.1 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.54 4.96 USD |
0
|
$7.59B 8.29B USD | $12 13.12 USD | $4.5 4.92 USD | $4.58 5.01 USD | $7.59B 8.29B USD | 0 | -$0.01 -0.01 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.45 — |
0
|
$8.26B — | $2.5K — | $0.45 — | $0.45 — | $8.26B — | 45.39 | $0.01 — | |
|
Keine Lieblingsaktien
Sie haben noch keine Lieblingsaktie, bitte fügen Sie sie zu den Favoriten hinzu, um sie hier zu sehen |
||||||||||